SG Cowen Global Health Care Conference to Webcast Alkermes' Corporate Presentation

Business Wire, Nov 21, 2001

Business Editors & Health/Medical Writers

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 21, 2001

Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by SG Cowen on Wednesday, November 28, 2001 at 11:30am ET. The webcast may be viewed live at http://webcast.talkpoint.com/starthere.asp?pres=16601&template= sgcowen&exit=http://www.alkermes.com and will remain archived for 90 days.

James Frates, Chief Financial Officer of Alkermes, Inc., will present an overview of the company at 11:30am ET on Wednesday, November 28, 2001, from The Hotel Inter-Continental, Paris, France.

Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. Its first product, Nutropin Depot(R), is a long-acting form of Genentech's recombinant human growth hormone using Alkermes' ProLease(R) technology. The company has several areas of focus, including (i) controlled, sustained release of injectable drugs lasting several days to several weeks, utilizing its ProLease and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on proprietary pulmonary drug delivery technologies utilizing its AIR(TM) technology. In addition to its Cambridge, Massachusetts headquarters, research and manufacturing facilities, Alkermes operates research and manufacturing facilities in Ohio and a medical affairs office in Cambridge, England.